Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-007328
Filing Date
2024-03-11
Accepted
2024-03-11 16:13:14
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A govx20231231_10ka.htm   iXBRL 10-K/A 285944
2 EXHIBIT 31.3 ex_636593.htm EX-31.3 5644
3 EXHIBIT 31.4 ex_636594.htm EX-31.4 5506
  Complete submission text file 0001437749-24-007328.txt   559778

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20231231.xsd EX-101.SCH 3874
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20231231_def.xml EX-101.DEF 19399
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20231231_lab.xml EX-101.LAB 26036
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20231231_pre.xml EX-101.PRE 20256
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20231231_10ka_htm.xml XML 10445
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39563 | Film No.: 24738131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)